UNICA IRIS Institutional Research Information System

CARDIA, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 164.118
NA - Nord America 4.460
AS - Asia 880
AF - Africa 8
SA - Sud America 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 169.474
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 162.298
US - Stati Uniti d'America 4.406
CN - Cina 571
UA - Ucraina 541
SE - Svezia 438
DE - Germania 362
GB - Regno Unito 167
SG - Singapore 166
FI - Finlandia 125
FR - Francia 60
IN - India 39
CA - Canada 36
NL - Olanda 26
IR - Iran 23
KR - Corea 23
VN - Vietnam 23
RU - Federazione Russa 20
BE - Belgio 19
AT - Austria 17
VG - Isole Vergini Britanniche 16
PT - Portogallo 12
PK - Pakistan 10
PL - Polonia 10
IE - Irlanda 6
TR - Turchia 6
EG - Egitto 4
SA - Arabia Saudita 4
DK - Danimarca 3
HK - Hong Kong 3
ID - Indonesia 3
MU - Mauritius 3
AU - Australia 2
BR - Brasile 2
ES - Italia 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
RO - Romania 2
A1 - Anonimo 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
JP - Giappone 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 169.474
Salva come PNG Salva come JPEG
Città #
Cagliari 158.239
Uta 3.042
Chandler 494
Fairfield 429
Woodbridge 371
Nyköping 315
Jacksonville 296
Boardman 285
Ann Arbor 282
Ashburn 254
Houston 230
Dearborn 208
Wilmington 199
Seattle 168
Cambridge 134
Singapore 98
New York 96
Shanghai 95
Nanjing 91
Santa Clara 91
Beijing 66
Boston 56
Helsinki 56
Milan 52
Rome 47
Guangzhou 39
Nanchang 37
Shenyang 34
Redwood City 33
Toronto 27
Changsha 24
Parma 24
Dong Ket 22
San Diego 22
Seoul 22
Hebei 20
Verona 19
Jiaxing 18
Jinan 18
Nürnberg 18
Brussels 17
Los Angeles 17
Vienna 17
Road Town 16
Sassari 16
Orange 14
Tianjin 14
Mountain View 13
Naples 13
Norwalk 13
Auburn Hills 12
Padova 12
Florence 11
London 10
Bari 9
Bologna 9
Lodz 9
Augusta 8
Cosenza 8
Hangzhou 8
Hefei 8
Herndon 8
Kunming 8
Rende 8
Taizhou 8
Washington 8
Zhengzhou 8
Palermo 7
Saint Petersburg 7
Turin 7
Amsterdam 6
Chicago 6
Ningbo 6
Pavia 6
Salerno 6
Wuhan 6
Camden 5
Catania 5
Genoa 5
Messina 5
Mumbai 5
Ottawa 5
Pisa 5
Portici 5
Porto 5
Pune 5
San Mateo 5
Siracusa 5
Zerfalìu 5
Capoterra 4
Cesena 4
Costa Mesa 4
Istanbul 4
Lecce 4
Millbury 4
Modena 4
Munich 4
Rio Tinto 4
Tertenìa 4
Trieste 4
Totale 166.539
Salva come PNG Salva come JPEG
Nome #
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs 4.500
Formulation and characterization studies of trimethyl chitosan / sodium alginate nanoparticles for targeted drug delivery 4.483
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.214
Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro-in vivo suitability as pulmonary delivery systems 3.833
Investigating the interactions of resveratrol with phospholipid vesicle bilayer and the skin: NMR studies and confocal imaging 3.817
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.668
Preparazione di nanoparticelle di TMC per il rilascio di farmaci a livello oculare 3.382
Preparation and characterization of TMC nanoparticles for colon specific drug delivery 3.380
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.369
Sintesi e caratterizzazione chimico-fisica di un derivato del chitosano per la realizzazione di sistemi nanoparticellari 3.306
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.224
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.175
Synthesis And Characterization Of A Chitosan Derivative For The Preparation Of Nanoparticles 3.163
PREPARATION OF TMC NANOPARTICLES FOR OCULAR DELIVERY 3.147
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.139
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol 2.933
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2.847
null 2.749
NANOPARTICELLE A BASE DI TMC E SA PER LA VEICOLAZIONE NOSE TO BRAIN 2.730
SINTESI DI TMC A DIVERSO GRADO DI QUATERNIZZAZIONE PER LA REALIZZAZIONE DI SISTEMI NANOPARTICELLARI 2.665
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.533
PREPARAZIONE E CARATTERIZZAZIONE DI SISTEMI NANOPARTICELLARI DI TMC PER LA VEICOLAZIONE DI UN AGENTE ANTINFIAMMATORIO FITOTERAPICO MIRATO AL COLON 2.517
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.444
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.361
Preparazione e caratterizzazione di formulazioni cosmetiche contenenti olio di Neem 2.288
1H NMR study of the interaction of trans-resveratrol with soybean phosphatidylcholine liposomes 2.288
Nanoparticelle per la veicolazione nasale del Progesterone per il trattamento della malattia di Alzheimer 2.239
SYNTHESIS AND CHARACTERIZATION OF A CHITOSAN DERIVATIVE FOR THE PREPARATION OF NANOPARTICLES 2.239
New promising scaffolds for the inhibition of monoamine oxidase B 2.223
Preparation and Characterization of TMC/SA nanoparticles for nose to brain drug delivery 2.202
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.174
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.083
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.080
Approcci formulativi per ottimizzare l’incapsulazione nanoparticellare della Curcumina 2.039
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.001
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 1.988
null 1.949
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.889
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 1.876
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.857
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.850
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.807
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.794
Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin Delivery 1.751
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.724
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.633
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.610
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.602
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.570
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.543
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.500
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 1.437
null 1.415
null 1.406
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.370
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.333
Transcutol® p containing slns for improving 8-methoxypsoralen skin delivery 1.310
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.099
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.047
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.040
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and DFT calculations. Investigation on a case of very remote Hammett correlation 1.008
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 977
Progettazione e sintesi di 4-(5-ariliden-3-metil-4-ossotiazolidin-2-ilidenamino)benzensulfonamidi e 4-(5-alchiliden-3-metil-4-ossotiazolidin-2-ilidenammino)benzensulfonamidi quali potenziali inibitori selettivi delle ciclossigenasi 2 964
Preparazione di nanoparticelle TMC/Alginato per la veicolazione al SNC 957
null 943
Computational approaches for discovery and optimization of monoamine oxidase B inhibitors 941
Proniosomal formulation encapsulating pomegranate peel extract for nutraceutical applications 926
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 894
1-benzenesulfonamide-1(H)-pyrazoles and 3-benzenesulfonamide-4-tiazolidinones, two promising scaffolds for the design of cycloxygenase inhibitors 877
CoMFA studies of non-covalent monoamine oxidase inhibitors 868
Tri-substituted thiazolines as promising scaffolds for the design of efficient COX inhibitors 855
Pulmonary delivery of curcumin and beclomethasone dipropionate in a multicomponent nanosuspension for the treatment of bronchial asthma 850
Combining induced fit docking and molecular dynamics simulations to predict the binding mode of new monoamine oxidase B inhibitors 847
Sintesi di cicloalchilidenidrazo-4-ariltiazoli ad elevata attività inibitrice selettiva sulla isoforma B delle monoammino ossidasi 822
1-acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazole; a new scaffold for monoaminoxidase inhibitors: design, synthesis, and biological properties 820
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 818
null 818
Computational and experimental study of non-covalent monoamine oxidase inhibitors 794
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives 790
Novel MAO-B selective inhibitors developed using computational methods 786
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 761
Topoisomerase I: synthesis of a new class of potential inhibitors 761
null 735
null 693
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 680
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 628
Impact of solid lipid nanoparticles on 3T3 fibroblasts viability and lipid profile: The effect of curcumin and resveratrol loading 627
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 622
null 617
null 610
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 592
Synthesis of new arylidencycloalkylpyrazoles of biological interest 532
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent 480
Bentonite- and Palygorskite-Based Gels for Topical Drug Delivery Applications 400
Isonicotinoylhydrazothiazoles and isonicotinoyl-N-4-substituted thiosemicarbazides: Synthesis, characterization, and anti-mycobacterial activity 398
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. Investigation on a case of very remote Hammett correlation 386
New cycloalkylpyrazoles as potential cyclooxygenase inhibitors 327
Clay-Based Hydrogels as Drug Delivery Vehicles of Curcumin Nanocrystals for Topical Application 320
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives 320
Synthesis, Molecular Modeling Studies, and Selective Inhibitory Activity against Monoamine Oxidase of 1-Thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole Derivatives 253
Totale 169.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 194.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.915
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.754 0 0 0 0 0 0 3.507 904 765 995 893 1.690
2020/202140.495 1.671 1.591 2.139 9.915 7.834 4.334 3.610 2.304 1.159 2.327 2.291 1.320
2021/20227.147 991 765 320 378 597 490 481 334 590 590 805 806
2022/202312.131 945 1.574 1.399 1.156 816 1.103 753 965 670 997 1.198 555
2023/202413.892 494 654 1.153 916 1.496 2.115 2.025 1.026 819 715 1.134 1.345
2024/202519.302 3.608 4.952 5.648 2.362 1.250 1.438 44 0 0 0 0 0
Totale 169.688